Search

Author/Creator Baker, Mark

12. Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial. Issue 1 (January 2016)

Authors:
Phyo, Aung Pyae; Jittamala, Podjanee; Nosten, François H; Pukrittayakamee, Sasithon; Imwong, Mallika; White, Nicholas J; Duparc, Stephan; Macintyre, Fiona; Baker, Mark; Möhrle, Jörg J
Journal:
Lancet infectious diseases
Issue:
Volume 16:Issue 1(2016:Jan.)
Page Start:
61
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study. Issue 8 (August 2018)

Authors:
Llanos-Cuentas, Alejandro; Casapia, Martin; Chuquiyauri, Raúl; Hinojosa, Juan-Carlos; Kerr, Nicola; Rosario, Maria; Toovey, Stephen; Arch, Robert H; Phillips, Margaret A; Rozenberg, Felix D; Bath, Jade; Ng, Caroline L; Cowell, Annie N; Winzeler, Elizabeth A; Fidock, David A; Baker, Mark; Möhrle, ...
Journal:
Lancet infectious diseases
Issue:
Volume 18:Issue 8(2018)
Page Start:
874
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗